We are live on ! Find out more
TCP

Tyndall Capital Partners Portfolio holdings

AUM $452K
1-Year Est. Return 26.52%
This Fund
S&P 500
This Quarter Est. Return
+16.4%
1 Year Est. Return
+26.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$452K
AUM Growth
+$39.7K
Cap. Flow
-$28.6K
Cap. Flow %
-6.34%
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
1
Closed
–
Avg Time Held
7 quarters
Top 10 Avg Time Held
7 quarters
Top 20 Avg Time Held
7 quarters

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
KRSA
Korsana Biosciences, Inc. Common Stock
KRSA
+$28.6K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
KRSA
1
Korsana Biosciences, Inc. Common Stock
KRSA
$1.54B
$452K 100%
22,170
-1,370
-6% -$28.6K
2023 Q3
7 quarters

Similar funds

CCM
Cota Capital Management San Francisco, California $177K AUM 63.94% 1-Year Est. Return
HIP
Hatteras Investment Partners Raleigh, North Carolina $169K AUM 86.49% 1-Year Est. Return
BPWM
Black Point Wealth Management Naples, Florida $3.5M AUM 16.42% 1-Year Est. Return
NP
Newlight Partners New York $3.9M AUM 96.05% 1-Year Est. Return
CP
Castalian Partners Excelsior, Minnesota $7.36M AUM
AI
Allostery Investments Stamford, Connecticut $7.85M AUM
CAWM
Capital A Wealth Management New Castle, Pennsylvania $8.94M AUM
ADIM
Alpha DNA Investment Management Columbia, Maryland $8.98M AUM 26.05% 1-Year Est. Return

Tyndall Capital Partners's Q2 2025 Portfolio in Review

As of Q2 2025, Tyndall Capital Partners held 1 position worth $452K, up 9.6% from $412K the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tyndall Capital Partners withdrew a net $28.6K in Q2 2025, reducing 1 holding. Its largest reduction was Korsana Biosciences, Inc. Common Stock, cutting an estimated $28.6K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Tyndall Capital Partners's biggest Q2 2025 reduction was Korsana Biosciences, Inc. Common Stock, cutting an estimated $28.6K.
  • Tyndall Capital Partners's ten largest holdings make up 100% of its $452K portfolio in Q2 2025.
  • Tyndall Capital Partners opened 0 new positions and closed 0 in Q2 2025.
  • Tyndall Capital Partners's portfolio value rose 9.6% quarter-over-quarter to $452K.

Based on Tyndall Capital Partners's 13F filing for Q2 2025, filed 14 Aug 2025.